ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1496

A Metagenome-wide Association Study Revealed Disease-specific Landscape of the Gut Microbiome of Systemic Lupus Erythematosus in Japanese

Yoshihiko Tomofuji1, Yuichi Maeda2, Eri Oguro-Igashira2, Toshihiro Kishikawa1, Kenichi Yamamoto1, Kyuto Sonehara1, Daisuke Motooka3, Yuki Matsumoto3, Hidetoshi Matsuoka4, Maiko Yoshimura4, Mayu Yagita2, Takuro Nii2, Shiro Ohshima5, Shota Nakamura3, Hidenori Inohara6, Kiyoshi Takeda7, Atsushi Kumanogoh2 and Yukinori Okada1, 1Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan, 2Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Japan, 3Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Suita, Japan, 4Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan, 5Rheumatology and Allergology, NHO Osaka Minami Medical Center, Suita, Japan, 6Department of Otorhinolaryngology - Head and Neck Surgery, Osaka University Graduate School of Medicine, Suita, Japan, 7Laboratory of Immune Regulation, Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Suita, Japan

Meeting: ACR Convergence 2021

Keywords: gut microbiome, MWAS, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 9, 2021

Title: SLE – Etiology & Pathogenesis Poster (1480–1506)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Alteration of the gut microbiome has been linked to the pathogenesis of systemic lupus erythematosus (SLE). However, a comprehensive view of the gut microbiome in SLE and its interaction with the host remains to be revealed. This study aimed to reveal SLE-associated changes in the gut microbiome and its interaction with the host by a comprehensive metagenome-wide association study (MWAS) based on shotgun sequencing followed by integrative analysis.

Methods: We performed a MWAS of SLE based on shotgun sequencing of the gut microbial DNA from Japanese individuals (Ncase = 47, Ncontrol = 203). All of the 47 SLE patients were diagnosed according to the systemic lupus international collaborating clinics classification criteria (SLICC). Our MWAS consisted of three major bioinformatic analytic pipelines (phylogenetic analysis, functional gene analysis and pathway analysis). We integrated the result of the MWAS with the genome-wide association study (GWAS) data and plasma metabolite data.

Results: Via species level phylogenetic analysis, we identified and validated increases of Streptococcus interdemius and Streptococcus anginosus in the SLE patients (effect size = 0.617 and Pmicrobe = 3.7 × 10-5 for Streptococcus anginosus, effect size = 0.579 and Pmicrobe = 7.5 × 10-5 for Streptococcus intermedius; Figure 1). Microbial gene analysis revealed increases of the eight Streptococcus derived genes including one involved in redox reaction. Additionally, microbial pathways related to sulfur metabolism and flagella assembly were altered in the SLE patients. We identified a pathway level SLE-specific link between the metagenome and the germline genome by comparing the result of the current MWAS and the GWAS of SLE (i.e., MWAS-GWAS interaction). α- and β-diversity analyses provided evidence of dysbiosis in the metagenome of the SLE patients (Figure 2). Microbiome-metabolome association analysis identified positive dosage correlation of acylcarnitine with Streptococcus intermedius, an SLE-associated taxon (Figure 3).

Conclusion: Our MWAS followed by integrative analysis revealed SLE-associated changes in the gut microbiome and its interaction with the host, which provided novel insights into the pathogenesis of SLE.

A phylogenetic tree. Levels L2-L7 are from the inside layer to the outside layer. The size and the color of nodes represent relative abundances and effect sizes, respectively. The two clades with significant case-control associations (FDR < 0.05) are outlined in red. FDR, false discovery ratio.

(A) α-diversities of the phylogenetic relative abundance data for the six taxonomic levels. Blue and green dots represent the median Shannon index of the HC and SLE subjects. Upper and lower dashed lines indicate the 1st and 3rd quantile of Shannon index for the HC and SLE subjects. (B) β-diversities of the phylogenetic relative abundance data at the species level. Result of NMDS based on Bray-Curtis distance is represented. Blue and green dots represent the HC and SLE subjects. HC, healthy control; IQR, interquartile range; NMDS, non-metric multidimensional scaling; SLE, systemic lupus erythematosus; *, P < 0.05; **, P < 0.0083.

(A) A quantile-quantile plot of the p-values from the microbe-metabolite association analysis. The x-axis indicates log-transformed empirically estimated median P-value. The y-axis indicates observed -log10(P). The diagonal dashed line represents y = x, which corresponds to the null hypothesis. The horizontal red dashed line indicates the Bonferroni-corrected threshold (α = 0.05), and the brown dashed line indicates the FDR threshold (FDR = 0.20) calculated with Benjamini-Hochberg method. The microbe-metabolite pairs with FDR < 0.20 are plotted as brown dots, and the other microbe-metabolite pairs are plotted as black dots. (B) A volcano plot. The x-axis indicates effect sizes in linear regression. The y-axis, horizontal dashed lines and dot colors are the same as in (A). FDR, false discovery rate; HC, healthy control; SLE, systemic lupus erythematosus.


Disclosures: Y. Tomofuji, None; Y. Maeda, None; E. Oguro-Igashira, None; T. Kishikawa, None; K. Yamamoto, None; K. Sonehara, None; D. Motooka, None; Y. Matsumoto, None; H. Matsuoka, None; M. Yoshimura, None; M. Yagita, None; T. Nii, None; S. Ohshima, None; S. Nakamura, None; H. Inohara, None; K. Takeda, None; A. Kumanogoh, None; Y. Okada, None.

To cite this abstract in AMA style:

Tomofuji Y, Maeda Y, Oguro-Igashira E, Kishikawa T, Yamamoto K, Sonehara K, Motooka D, Matsumoto Y, Matsuoka H, Yoshimura M, Yagita M, Nii T, Ohshima S, Nakamura S, Inohara H, Takeda K, Kumanogoh A, Okada Y. A Metagenome-wide Association Study Revealed Disease-specific Landscape of the Gut Microbiome of Systemic Lupus Erythematosus in Japanese [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-metagenome-wide-association-study-revealed-disease-specific-landscape-of-the-gut-microbiome-of-systemic-lupus-erythematosus-in-japanese/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-metagenome-wide-association-study-revealed-disease-specific-landscape-of-the-gut-microbiome-of-systemic-lupus-erythematosus-in-japanese/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology